Cover Image

Olmesartan medoxomil self-microemulsifying drug delivery system reverses apoptosis and improves cell adhesion in trinitrobenzene sulfonic acid-induced colitis in rats

Olmesartan medoxomil (OM) is an angiotensin receptor blocker. This study aimed to investigate the effects of OM self-microemulsifying drug delivery system (OMS) in trinitrobenzene sulfonic acid (TNBS)-induced acute colitis in rats. Besides two control groups, five TNBS-colitic-treated groups (n = 8)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hussam Murad (Author), Osama Ahmed (Author), Thamer Alqurashi (Author), Mostafa Hussien (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mouse model of ulcerative colitis using trinitrobenzene sulfonic acid
by: Irfan Ahmad Rather, et al.
Published: (2015)

Dual role of endogenous serotonin in 2,4,6-trinitrobenzene sulfonic acid-induced colitis
by: Alberto eRapalli, et al.
Published: (2016)

Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
by: Hetal Paresh Thakkar, et al.
Published: (2011)

KGF Is Delivered to Inflammatory and Induces the Epithelial Hyperplasia in Trinitrobenzene Sulfonic Acid-Induced Ulcerative Colitis Rats
by: Jia K, et al.
Published: (2020)

An Improved and Reliable Method for the Induction of Colitis in Rats Using 2,4,6-Trinitrobenzene Sulfonic Acid
by: Masayuki Uchida, et al.
Published: (2005)

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
by: Punzi HA
Published: (2011)

Sishen Wan® Ameliorated Trinitrobenzene-Sulfonic-Acid-Induced Chronic Colitis via NEMO/NLK Signaling Pathway
by: Hai-Yan Wang, et al.
Published: (2019)

Olmesartan medoxomil-loaded mixed micelles: Preparation, characterization and in-vitro evaluation
by: Mohamed A. El-Gendy, et al.
Published: (2017)

Thromboxane A2 Up-Regulates Neutrophil Elastase Release in Syrian Hamsters With Trinitrobenzene Sulfonic Acid-Induced Colitis
by: Yasushi Hirota, et al.
Published: (2005)

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation
by: Rania Moataz El-Dahmy, et al.
Published: (2023)

Milk Whey Culture With Propionibacterium freudenreichii ET-3 Is Effective on the Colitis Induced by 2,4,6-Trinitrobenzene Sulfonic Acid in Rats
by: Masayuki Uchida, et al.
Published: (2005)

Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology
by: Zenab Attari, et al.
Published: (2016)

Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice
by: Zhu Y, et al.
Published: (2019)

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
by: Jan Basile
Published: (2010)

Visceral hypersensitivity is provoked by 2,4,6-trinitrobenzene sulfonic acid-induced ileitis in rats
by: Manoj Kumar Shah, et al.
Published: (2016)

Rapamycin Alleviates 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis through Autophagy Induction and NF-κB Pathway Inhibition in Mice
by: Zhen Ni, et al.
Published: (2022)

Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
by: Ijlal Uddin, et al.
Published: (2010)

In silico assessment of chronic toxicity of a combination drug namely 'Olmesartan medoxomil and Hydrochlorothiazide', marketed in Bangladesh
by: Matrika Saha Roy, et al.
Published: (2021)

Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
by: Mac Arturo Murillo-Fernández, et al.
Published: (2022)

Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action
by: Jagdish Kumar Arun, et al.
Published: (2020)

α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way
by: Andrea Grandi, et al.
Published: (2017)

Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic/toxicity prediction study
by: Hussam Aly Sayed Murad, et al.
Published: (2022)

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis
by: Sievers P, et al.
Published: (2015)

The effect of trinitrobenzene sulfonic acid on gut-derived smooth muscle cell arachidonic acid metabolism: role of endogenous prostanoids
by: W. E. Longo, et al.
Published: (1997)

Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation
by: Ali Nasr, et al.
Published: (2016)

Cleaning validation for residual estimation of olmesartan medoxomil on stainless steel surface of pharmaceutical manufacturing equipments using swab sampling and HPLC-DAD method
by: Nitin Dubey, et al.
Published: (2013)

Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice
by: Hyun Yang-Jin, et al.
Published: (2010)

Histopathological analysis of 2,4,5-trinitrobenzene sulphonic acid (TNBS)-induced mouse colitis
by: Kang-Ho Choi, et al.
Published: (2016)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
by: Park JS, et al.
Published: (2016)

Enteropatía por olmesartán
Published: (2017)

Enteropatía asociada a Olmesartan
by: Virginia González Hidalgo, et al.
Published: (2021)

Platelet-activating factor mediates trinitrobenzene induced dysmotility in the left colon
by: W. E. Longo, et al.
Published: (1995)

Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice
by: Jiangtao Zhou, et al.
Published: (2017)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
by: Daikuhara H, et al.
Published: (2014)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
by: Takami T, et al.
Published: (2013)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
by: Takami T, et al.
Published: (2013)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
by: Menco G. Niemeijer, et al.
Published: (2009)

Determination of genotoxic alkyl methane sulfonates and alkyl paratoluene sulfonates in lamivudine using hyphenated techniques
by: N.V.V.S.S. Raman, et al.
Published: (2012)

Formulation and Characterization of Self-Microemulsifying Drug Delivery System of Tacrolimus
by: Duaa J. Al-Tamimi, et al.
Published: (2021)

Improved Therapeutic Efficacy of MT102, a New Anti-Inflammatory Agent, via a Self-Microemulsifying Drug Delivery System, in Ulcerative Colitis Mice
by: Kshitis Chandra Baral, et al.
Published: (2023)